Cost to import, border compliance (US$) in Canada was reported at 172 USD in 2019, according to the World Bank collection of development indicators, compiled from officially recognized sources. Canada - Cost to import, border compliance (US$) - actual values, historical data, forecasts and projections were sourced from the World Bank on November of 2025.

Sending remittances to Mexico was about **** percentage points cheaper than sending money from either Canada or the United States. This is according to an average taken from different situations in which consumers send money worth 200 U.S. dollars from one country to the next - including cash, MTOs (money transfer organizations) or cards.

Actual value and historical data chart for Canada Cost To Import Documentary Compliance Us$

Graph and download economic data for Estimated Mean Real Household Wages Adjusted by Cost of Living for Canadian County, OK (MWACL40017) from 2009 to 2023 about Canadian County, OK; Oklahoma City; OK; adjusted; average; wages; real; and USA.

Graph and download economic data for Unit Labor Costs in Manufacturing, U.S. Dollar Basis, in Canada (DISCONTINUED) (CANULCM) from 1950 to 2011 about unit labor cost, Canada, and manufacturing.

Actual value and historical data chart for Canada Cost To Export Border Compliance Us$

United States Crude Oil Price: EIA: Landed Cost of Imports: Canada data was reported at 57.310 USD/Barrel in Aug 2018. This records a decrease from the previous number of 59.000 USD/Barrel for Jul 2018. United States Crude Oil Price: EIA: Landed Cost of Imports: Canada data is updated monthly, averaging 25.060 USD/Barrel from Oct 1973 (Median) to Aug 2018, with 539 observations. The data reached an all-time high of 122.830 USD/Barrel in Jul 2008 and a record low of 4.820 USD/Barrel in Oct 1973. United States Crude Oil Price: EIA: Landed Cost of Imports: Canada data remains active status in CEIC and is reported by Energy Information Administration. The data is categorized under Global Database’s United States – Table US.P002: Energy Price.

Remitting from Canada incurred an average cost of **** percent in the first quarter of 2025, a decrease when compared to the previous year. The cost of sending money from the North American country was at its highest in late 2011, and generally declined since. The source adds that outgoing remittances from Canada were slightly more expensive than the average for the G20 countries, which was estimated at **** percent for sending money worth *** U.S. dollars.

Actual value and historical data chart for Canada Cost To Export Documentary Compliance Us$

This statistic shows the median amount charged by mobile development companies in the United States and Canada to develop applications for various major platforms and environments, as of 2017. As of that time, the median cost for mobile app development for iOS was 95 U.S. dollars per hour.

Background Even though the annual incidence rate of measles has dramatically decreased in industrialised countries since the implementation of universal immunisation programmes, cases continue to occur in countries where endemic measles transmission has been interrupted and in countries where adequate levels of immunisation coverage have not been maintained. The objective of this study is to develop a model to estimate the average cost per measles case and per adverse event following measles immunisation using the Netherlands (NL), the United Kingdom (UK) and Canada as examples. Methods Parameter estimates were based on a review of the published literature. A decision tree was built to represent the complications associated with measles cases and adverse events following imminisation. Monte-Carlo Simulation techniques were used to account for uncertainty. Results From the perspective of society, we estimated the average cost per measles case to be US$276, US$307 and US$254 for the NL, the UK and Canada, respectively, and the average cost of adverse events following immunisation per vaccinee to be US$1.43, US$1.93 and US$1.51 for the NL, UK and Canada, respectively. Conclusions These average cost estimates could be combined with incidence estimates and costs of immunisation programmes to provide estimates of the cost of measles to industrialised countries. Such estimates could be used as a basis to estimate the potential economic gains of global measles eradication.

View market daily updates and historical trends for US Dollar to Canadian Dollar Exchange Rate. from Canada. Source: European Central Bank. Track economic…

Low-income consumers in the United States and Canada pay the highest net transaction costs as a percentage of their purchases.

View yearly updates and historical trends for US Landed Cost of Crude Oil Imports From Canada. from United States. Source: Energy Information Administrati…

Monthly average retail prices for selected products, for Canada, provinces, Whitehorse and Yellowknife. Prices are presented for the current month and the previous four months. Prices are based on transaction data from Canadian retailers, and are presented in Canadian current dollars.

As of 2024, the average cost of a data breach in the United States amounted to **** million U.S. dollars, down from **** million U.S. dollars in the previous year. The global average cost per data breach was **** million U.S. dollars in 2024. Cost of a data breach in different countries worldwide Data breaches impose a big threat for organizations globally. The monetary damage caused by data breaches has increased in many markets in the past decade. In 2023, Canada followed the U.S. by data breach costs, with an average of **** million U.S. dollars. Since 2019, the average monetary damage caused by loss of sensitive information in Canada has increased notably. In the United Kingdom, the average cost of a data breach in 2024 amounted to around **** million U.S. dollars, while in Germany it stood at **** million U.S. dollars. The cost of data breach by industry and segment Data breach costs vary depending on the industry and segment. For the fourth consecutive year, the global healthcare sector registered the highest costs of data breach, which in 2024 amounted to about **** million U.S. dollars. Financial institutions ranked second, with an average cost of *** million U.S. dollars for a data breach. Detection and escalation was the costliest segment in data breaches worldwide, with **** U.S. dollars on average. The cost for lost business ranked second, while response following a breach came across as the third-costliest segment.

BackgroundThe National Lung Screening Trial (NLST) results indicate that computed tomography (CT) lung cancer screening for current and former smokers with three annual screens can be cost-effective in a trial setting. However, the cost-effectiveness in a population-based setting with >3 screening rounds is uncertain. Therefore, the objective of this study was to estimate the cost-effectiveness of lung cancer screening in a population-based setting in Ontario, Canada, and evaluate the effects of screening eligibility criteria.Methods and FindingsThis study used microsimulation modeling informed by various data sources, including the Ontario Health Insurance Plan (OHIP), Ontario Cancer Registry, smoking behavior surveys, and the NLST. Persons, born between 1940 and 1969, were examined from a third-party health care payer perspective across a lifetime horizon. Starting in 2015, 576 CT screening scenarios were examined, varying by age to start and end screening, smoking eligibility criteria, and screening interval. Among the examined outcome measures were lung cancer deaths averted, life-years gained, percentage ever screened, costs (in 2015 Canadian dollars), and overdiagnosis. The results of the base-case analysis indicated that annual screening was more cost-effective than biennial screening. Scenarios with eligibility criteria that required as few as 20 pack-years were dominated by scenarios that required higher numbers of accumulated pack-years. In general, scenarios that applied stringent smoking eligibility criteria (i.e., requiring higher levels of accumulated smoking exposure) were more cost-effective than scenarios with less stringent smoking eligibility criteria, with modest differences in life-years gained. Annual screening between ages 55–75 for persons who smoked ≥40 pack-years and who currently smoke or quit ≤10 y ago yielded an incremental cost-effectiveness ratio of $41,136 Canadian dollars ($33,825 in May 1, 2015, United States dollars) per life-year gained (compared to annual screening between ages 60–75 for persons who smoked ≥40 pack-years and who currently smoke or quit ≤10 y ago), which was considered optimal at a cost-effectiveness threshold of $50,000 Canadian dollars ($41,114 May 1, 2015, US dollars). If 50% lower or higher attributable costs were assumed, the incremental cost-effectiveness ratio of this scenario was estimated to be $38,240 ($31,444 May 1, 2015, US dollars) or $48,525 ($39,901 May 1, 2015, US dollars), respectively. If 50% lower or higher costs for CT examinations were assumed, the incremental cost-effectiveness ratio of this scenario was estimated to be $28,630 ($23,542 May 1, 2015, US dollars) or $73,507 ($60,443 May 1, 2015, US dollars), respectively.This scenario would screen 9.56% (499,261 individuals) of the total population (ever- and never-smokers) at least once, which would require 4,788,523 CT examinations, and reduce lung cancer mortality in the total population by 9.05% (preventing 13,108 lung cancer deaths), while 12.53% of screen-detected cancers would be overdiagnosed (4,282 overdiagnosed cases). Sensitivity analyses indicated that the overall results were most sensitive to variations in CT examination costs. Quality of life was not incorporated in the analyses, and assumptions for follow-up procedures were based on data from the NLST, which may not be generalizable to a population-based setting.ConclusionsLung cancer screening with stringent smoking eligibility criteria can be cost-effective in a population-based setting.

These are peer-reviewed supplementary materials for the article 'The economic impact of stent retriever selection for acute ischemic stroke: a cost analysis of MASTRO I from the healthcare system perspective of the United States, Canada and eight European countries' published in the Journal of Comparative Effectiveness Research.Supplementary Tables and FiguresSupplementary Table 1: Economic Outcomes of Probabilistic Scenario Analyses Supplementary Figure 1: Tornado Diagrams for Per-Patient Incremental Cost – US AnalysisSupplementary Figure 2: Tornado Diagrams for Per-Patient Incremental Cost – Canada AnalysisSupplementary Figure 3: Tornado Diagrams for Per-Patient Incremental Cost – UK AnalysisSupplementary Figure 4: Tornado Diagrams for Per-Patient Incremental Cost – Sweden AnalysisSupplementary Figure 5: Tornado Diagrams for Per-Patient Incremental Cost – Germany AnalysisSupplementary Figure 6: Tornado Diagrams for Per-Patient Incremental Cost – France AnalysisSupplementary Figure 7: Tornado Diagrams for Per-Patient Incremental Cost – Italy AnalysisSupplementary Figure 8: Tornado Diagrams for Per-Patient Incremental Cost – Spain AnalysisSupplementary Figure 9: Tornado Diagrams for Per-Patient Incremental Cost – Belgium AnalysisSupplementary Figure 10: Tornado Diagrams for Per-Patient Incremental Cost – The Netherlands AnalysisSupplementary MethodsCost Inputs for GermanyCost Inputs for FranceCost Inputs for The NetherlandsSupplementary Material ReferencesAim: According to the results of the MASTRO I living systematic review and meta-analysis, use of the EmboTrap Revascularization Device in the treatment of acute ischemic stroke (AIS) results in higher rates of good functional outcomes (90-day modified Rankin Scale [mRS] 0–2) compared with use of the Trevo Retriever or the Solitaire™ Revascularization Device. The aim of this analysis was to assess the potential economic impact of achieving improved functional outcomes for three commonly used stent retrievers (SRs) in the treatment of AIS. Methods: An economic modelwith short-term and long-term costs, representing a healthcare system perspective was developed using a decision tree to simulate a cohort of 1000 hypothetical patients treated for AIS with mechanical thrombectomy (MT) using EmboTrap, Trevo or Solitaire SRs. Based on the proportion of patients who achieved a 90-day mRS score of 0–2 or 3–5 for each device reported in MASTRO I (excluding patients not surviving after 90 days), this model estimated per-patient costs and the associated incremental cost savings. Results are reported from the healthcare system perspective in the US, Canada, the UK, Sweden, Germany, France, Italy, Spain, Belgium and The Netherlands. Results: Across all ten countries, the use of EmboTrap during MT was associated with the lowest short-term (ranging from €8412 in Italy to $66,525 in the US), long-term (ranging from €5249 in Italy to $25,757 in the US) and total (ranging from €13,661 in Italy to $92,282 in the US) per-patient costs. The total per-patient cost was higher with Trevo (ranging from €14,601 in Italy to $97,487 in the US) and Solitaire (ranging from €14,840 in Italy to $98,814 in the US). Cost savings were highest when comparing EmboTrap versus Solitaire, followed by EmboTrap versus Trevo, with Trevo versus Solitaire having the smallest cost savings. Results of sensitivity and scenario analyses supported the robustness of the basecase results. Conclusion: Across the ten countries, treating patients with AIS with EmboTrap resulted in lower short-term, long-term and total costs to the payer. With rising healthcare costs and limited hospital budgets, these results suggest EmboTrap proves to be an evidence-based economical choice of SR for hospitals and healthcare systems.

Average spending on specific measures to recover from cyber security incidents by the North American Industry Classification System (NAICS) and size of enterprise.

Cybercrime costs in Canada reached an estimated 3.82 billion U.S. dollars as of 2023. Between 2017 and 2023, this figure gradually increased. According to the latest estimates, this dynamic will continue in upcoming years, reaching approximately 4.78 billion U.S. dollars in cybercrime costs by 2028.